Chimin(SH:603222)2025-10-30 08:55Financial Performance - The company's operating revenue for the third quarter was ¥178,268,850.64, a decrease of 17.86% compared to the same period last year[4]. - The total profit for the third quarter was -¥33,081,417.78, representing a decline of 1,749.03% year-on-year[4]. - The net profit attributable to shareholders was -¥24,454,507.27, down 923.38% from the previous year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥23,334,321.39, a decrease of 1,054.49% year-on-year[4]. - The basic earnings per share for the third quarter was -¥0.0468, a decline of 920.18% compared to the same period last year[5]. - Total operating revenue for the first three quarters of 2025 was ¥544.72 million, a decrease of 20.2% compared to ¥682.67 million in the same period of 2024[19]. - Net profit for the first three quarters of 2025 was a loss of ¥75.37 million, compared to a profit of ¥33.40 million in 2024, representing a significant decline[20]. - The total comprehensive income for the first three quarters of 2025 was a loss of ¥68.04 million, compared to a gain of ¥33.03 million in 2024[21]. - The company’s basic and diluted earnings per share for the first three quarters of 2025 were both -¥0.1473, compared to ¥0.0538 in 2024[21]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,495,960,023.97, an increase of 3.38% from the end of the previous year[5]. - The equity attributable to shareholders decreased by 5.53% to ¥1,398,916,578.17 compared to the end of the previous year[5]. - The total liabilities increased to RMB 1,007,920,871.09 from RMB 846,220,952.60, representing a growth of approximately 19.1%[16]. - The company's total current liabilities reached RMB 665,932,667.63, an increase from RMB 486,577,856.37, reflecting a growth of approximately 37%[16]. - The company's equity attributable to shareholders decreased to RMB 1,398,916,578.17 from RMB 1,480,824,869.60, a decline of about 5.5%[16]. Cash Flow - The cash flow from operating activities for the year-to-date was -¥32,252,594.88, a decline of 172.82% compared to the previous year[4]. - The company reported a net cash outflow from operating activities of ¥32.25 million in 2025, compared to an inflow of ¥44.29 million in 2024[24]. - Cash and cash equivalents at the end of the third quarter of 2025 were ¥253.50 million, down from ¥172.60 million at the end of the same period in 2024[24]. - The company raised ¥397.88 million through financing activities in 2025, significantly higher than the ¥176.00 million raised in 2024[24]. - The company’s investment activities generated a net cash outflow of ¥191.31 million in 2025, compared to a smaller outflow of ¥88.21 million in 2024[24]. Inventory and Receivables - The company plans to further assess inventory impairment provisions due to reduced sales and market conditions affecting product lines[6]. - The company reported a decrease in inventory from RMB 174,108,449.24 to RMB 134,461,736.70, a reduction of about 22.8%[15]. - Accounts receivable rose to RMB 150,060,274.17, up from RMB 126,974,794.39, indicating an increase of about 18.2%[14]. Share Repurchase and Legal Matters - The company repurchased a total of 2,005,500 shares for a total amount of RMB 12,089,000 as of September 2025[13]. - The company plans to repurchase shares at a price not exceeding RMB 10.00 per share, with a total repurchase fund between RMB 100 million and RMB 200 million[12]. - The company is involved in ongoing legal cases with a total claim amount of RMB 6,950.26 million from primary distributors and RMB 1,707.66 million from secondary distributors[13]. Accounting Changes - The new accounting standards or interpretations will be implemented starting from 2025, affecting the financial statements at the beginning of the year of first-time application[25]. - The announcement was made by the board of directors of Jimin Health Management Co., Ltd. on October 31, 2025[26].